You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

ACUTECT Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Acutect, and what generic alternatives are available?

Acutect is a drug marketed by Cis Bio Intl Sa and is included in one NDA.

The generic ingredient in ACUTECT is technetium tc-99m apcitide. There are four drug master file entries for this compound. Additional details are available on the technetium tc-99m apcitide profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ACUTECT?
  • What are the global sales for ACUTECT?
  • What is Average Wholesale Price for ACUTECT?
Summary for ACUTECT
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 2
DailyMed Link:ACUTECT at DailyMed
Drug patent expirations by year for ACUTECT

US Patents and Regulatory Information for ACUTECT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cis Bio Intl Sa ACUTECT technetium tc-99m apcitide INJECTABLE;INJECTION 020887-001 Sep 14, 1998 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ACUTECT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cis Bio Intl Sa ACUTECT technetium tc-99m apcitide INJECTABLE;INJECTION 020887-001 Sep 14, 1998 ⤷  Sign Up ⤷  Sign Up
Cis Bio Intl Sa ACUTECT technetium tc-99m apcitide INJECTABLE;INJECTION 020887-001 Sep 14, 1998 ⤷  Sign Up ⤷  Sign Up
Cis Bio Intl Sa ACUTECT technetium tc-99m apcitide INJECTABLE;INJECTION 020887-001 Sep 14, 1998 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for ACUTECT

See the table below for patents covering ACUTECT around the world.

Country Patent Number Title Estimated Expiration
European Patent Office 0804481 DERIVES DE SOMATOSTATINE ET LEURS PRODUITS RADIOMARQUES (SOMATOSTATIN DERIVATIVES AND THEIR RADIOLABELLED PRODUCTS) ⤷  Sign Up
South Africa 9403984 ⤷  Sign Up
Japan H10501241 ⤷  Sign Up
World Intellectual Property Organization (WIPO) 9419024 ⤷  Sign Up
China 1154072 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for ACUTECT

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1178838 300736 Netherlands ⤷  Sign Up PRODUCT NAME: TILMANOCEPT, DESGEWENST GELABELD MET TECHNETIUM TC 99M; REGISTRATION NO/DATE: EU/1/14/955 20141119
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.